<?xml version='1.0' encoding='utf-8'?>
<document id="15618696"><sentence text="Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase--effect of cMOAT deficiency on hepatobiliary excretion in rats and of mdr1a/b gene disruption on tissue distribution in mice."><entity charOffset="18-30" id="DDI-PubMed.15618696.s1.e0" text="pitavastatin" /></sentence><sentence text="Pitavastatin is a potent competitive inhibitor of HMG-CoA reductase"><entity charOffset="0-12" id="DDI-PubMed.15618696.s2.e0" text="Pitavastatin" /></sentence><sentence text=" In the current study, to elucidate the hepatobiliary excretion of pitavastatin, we investigated the plasma concentration and biliary excretion of (14)C-pitavastatin in EHBR"><entity charOffset="67-79" id="DDI-PubMed.15618696.s3.e0" text="pitavastatin" /><entity charOffset="147-165" id="DDI-PubMed.15618696.s3.e1" text="(14)C-pitavastatin" /><pair ddi="false" e1="DDI-PubMed.15618696.s3.e0" e2="DDI-PubMed.15618696.s3.e0" /><pair ddi="false" e1="DDI-PubMed.15618696.s3.e0" e2="DDI-PubMed.15618696.s3.e1" /></sentence><sentence text=" We also evaluated the distribution of pitavastatin in mdr1a/b knockout mice by whole body autoradiography and quantitative radioassay"><entity charOffset="39-51" id="DDI-PubMed.15618696.s4.e0" text="pitavastatin" /></sentence><sentence text=" In view of the widespread clinical use of pitavastatin and the importance of drug-drug interaction, the inhibitory effect on Pgp-mediated activation of ATPase was also investigated"><entity charOffset="43-55" id="DDI-PubMed.15618696.s5.e0" text="pitavastatin" /></sentence><sentence text=" No marked difference was observed in the plasma concentration and biliary excretion of radioactivity between SDR and EHBR after dosing of (14)C-pitavastatin"><entity charOffset="139-157" id="DDI-PubMed.15618696.s6.e0" text="(14)C-pitavastatin" /></sentence><sentence text=" Little radioactive transfer into the brain was detected in mdr1a/b knockout mice and the ATPase activity of human Pgp was negligible in the presence of pitavastatin"><entity charOffset="153-165" id="DDI-PubMed.15618696.s7.e0" text="pitavastatin" /></sentence><sentence text=" Moreover, no inhibitory effect on the Pgp-mediated activation of ATPase by verapamil was found in the presence of pitavastatin over a wide concentration range"><entity charOffset="76-85" id="DDI-PubMed.15618696.s8.e0" text="verapamil" /><entity charOffset="115-127" id="DDI-PubMed.15618696.s8.e1" text="pitavastatin" /><pair ddi="false" e1="DDI-PubMed.15618696.s8.e0" e2="DDI-PubMed.15618696.s8.e0" /><pair ddi="false" e1="DDI-PubMed.15618696.s8.e0" e2="DDI-PubMed.15618696.s8.e1" /></sentence><sentence text=" These results indicated that a cMOAT and Pgp-mediated transport mechanism did not play a major role in the distribution of pitavastatin"><entity charOffset="124-136" id="DDI-PubMed.15618696.s9.e0" text="pitavastatin" /></sentence><sentence text="" /></document>